Clinical Trial Update: Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating azithromycin to promote readthrough of APC stop codon mutations in familial adenomatous polyposis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Adenomatous Polyposis

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Familial Adenomatous Polyposis | Phase 4 | Status: UNKNOWN